# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 16, "J Fr Ophtalmol .", "", "<http://ctro/data#Publication_19083> <http://ctro/data#hasJournal> \"J Fr Ophtalmol .\"."
1, PublicationYear, 17, 21, "2003", "", "<http://ctro/data#Publication_19083> <http://ctro/data#hasPublicationYear> \"2003\"."
135, Title, 51, 114, "Efficacy and safety of long - acting carteolol 1 % once daily .", "", "<http://ctro/data#Publication_19083> <http://ctro/data#hasTitle> \"Efficacy and safety of long - acting carteolol 1 % once daily .\"."
60704, Drug, 74, 97, "long - acting carteolol", "", 
60561, Carteolol, 88, 97, "carteolol", "", 
60559, DoseValue, 98, 99, "1", "", 
3, Percentage, 100, 101, "%", "", 
4, Frequency, 102, 112, "once daily", "", 
5, DoubleBlind, 117, 132, "double - masked", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
99, Randomized, 135, 145, "randomized", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
6, Author, 178, 189, "Trinquand C", "", "<http://ctro/data#Publication_19083> <http://ctro/data#hasAuthor> \"Trinquand C\"."
7, Author, 198, 208, "Romanet JP", "", "<http://ctro/data#Publication_19083> <http://ctro/data#hasAuthor> \"Romanet JP\"."
8, Author, 211, 222, "Nordmann JP", "", "<http://ctro/data#Publication_19083> <http://ctro/data#hasAuthor> \"Nordmann JP\"."
9, Author, 225, 234, "Allaire C", "", "<http://ctro/data#Publication_19083> <http://ctro/data#hasAuthor> \"Allaire C\"."
10, France, 335, 341, "France", "", "<http://ctro/data#Population_38937> <http://ctro/data#hasCountry> <http://ctro/data#France>."
87, Carteolol, 354, 363, "Carteolol", "", 
16, IOP, 467, 487, "intraocular pressure", "", 
100, Frequency, 514, 525, "twice daily", "", 
85, Frequency, 554, 566, "once - daily", "", 
88, Carteolol, 584, 593, "carteolol", "", 
101, DoseValue, 614, 615, "1", "", 
102, Percentage, 616, 617, "%", "", 
86, Carteolol, 760, 769, "carteolol", "", 
15, ObjectiveDescription, 803, 965, "The objective of this study was to evaluate the efficacy and safety of long - acting 1 % carteolol alginate solution compared to standard 1 % carteolol solution .", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasObjectiveDescription> \"The objective of this study was to evaluate the efficacy and safety of long - acting 1 % carteolol alginate solution compared to standard 1 % carteolol solution .\"."
103, DoseValue, 888, 889, "1", "", 
104, Percentage, 890, 891, "%", "", 
106383, Drug, 892, 910, "carteolol alginate", "", 
105, DoseValue, 941, 942, "1", "", "<http://ctro/data#Medication_38993> <http://ctro/data#hasDoseValue> \"1\"."
106, Percentage, 943, 944, "%", "", 
89, Carteolol, 945, 954, "carteolol", "", 
17, DoubleBlind, 987, 1002, "double - masked", "", 
149, Parallel, 1005, 1019, "parallel group", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
19, Multicenter, 1022, 1033, "multicentre", "", 
60563, Precondition, 1042, 1098, "Patients with ocular hypertension or open angle glaucoma", "", "<http://ctro/data#Population_38937> <http://ctro/data#hasPrecondition> \"Patients with ocular hypertension or open angle glaucoma\"."
20, OcularHypertension, 1056, 1075, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
21, OpenAngleGlaucoma, 1079, 1098, "open angle glaucoma", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OpenAngleGlaucoma>."
22, NumberPatientsCT, 1105, 1108, "151", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasNumberPatientsCT> \"151\"."
111, Randomized, 1116, 1124, "randomly", "", 
107, DoseValue, 1152, 1153, "1", "", "<http://ctro/data#Medication_38986> <http://ctro/data#hasDoseValue> \"1\"."
109, Percentage, 1154, 1155, "%", "", "<http://ctro/data#Medication_38986> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
95, Drug, 1156, 1174, "carteolol alginate", "", "<http://ctro/data#Drug_38987> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Drug>. <http://ctro/data#Medication_38986> <http://ctro/data#hasDrug> <http://ctro/data#Drug_38987>."
23, Frequency, 1175, 1185, "once daily", "", "<http://ctro/data#Intervention_38974> <http://ctro/data#hasFrequency> \"once daily\"."
158, Morning, 1188, 1190, "AM", "", "<http://ctro/data#Intervention_38974> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Morning>."
108, DoseValue, 1205, 1206, "1", "", 
110, Percentage, 1207, 1208, "%", "", "<http://ctro/data#Medication_38993> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
90, Carteolol, 1209, 1218, "carteolol", "", "<http://ctro/data#Medication_38993> <http://ctro/data#hasDrug> <http://ctro/data#Carteolol>."
24, Frequency, 1228, 1239, "twice daily", "", "<http://ctro/data#Intervention_38980> <http://ctro/data#hasFrequency> \"twice daily\"."
25, Duration, 1244, 1252, "2 months", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasCTduration> \"2 months\"."
60564, Blind, 1259, 1266, "masking", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind>."
26, Placebo, 1303, 1310, "placebo", "", "<http://ctro/data#Medication_98615> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
165, Evening, 1318, 1325, "evening", "", "<http://ctro/data#Intervention_98622> <http://ctro/data#hasRelativeFreqTime> <http://ctro/data#Evening>."
28, IOP, 1393, 1413, "intraocular pressure", "", 
29, IOP, 1416, 1419, "IOP", "", 
60565, DoseValue, 1430, 1432, "23", "", 
30, mmHg, 1433, 1437, "mmHg", "", 
60566, DoseValue, 1442, 1444, "32", "", 
31, mmHg, 1445, 1449, "mmHg", "", 
170, TimePoint, 1453, 1457, "9 AM", "", 
171, TimePoint, 1462, 1467, "11 AM", "", 
172, Precondition, 1470, 1551, "Patients using ocular hypotensive medication were required to undergo a washout .", "", "<http://ctro/data#Population_38937> <http://ctro/data#hasPrecondition> \"Patients using ocular hypotensive medication were required to undergo a washout .\"."
112, AngleClosureGlaucoma, 1644, 1657, "angle closure", "", 
113, Glaucoma, 1660, 1670, "congenital", "", 
114, Secondary_AngleClosureGlaucoma, 1673, 1691, "secondary glaucoma", "", 
116, Glaucoma, 1695, 1712, "advanced glaucoma", "", 
60582, DisorderOrSyndrome, 1719, 1756, "intraocular infection or inflammation", "", 
60584, DisorderOrSyndrome, 1759, 1772, "ocular trauma", "", 
60598, Duration, 1835, 1843, "3 months", "", 
60611, Drug, 1878, 1907, "beta adrenoceptor antagonists", "", 
32, IOP, 1948, 1951, "IOP", "", 
60599, Duration, 1995, 2003, "3 months", "", 
60606, Drug, 2006, 2020, "ocular steroid", "", 
120, TimePoint, 2109, 2117, "baseline", "", 
121, TimePoint, 2120, 2134, "15 and 60 days", "", 
122, TimePoint, 2127, 2134, "60 days", "", 
33, IOP, 2142, 2145, "IOP", "", 
189, TimePoint, 2162, 2166, "9 AM", "", 
190, TimePoint, 2171, 2176, "11 AM", "", 
123, TimePoint, 2182, 2188, "day 15", "", 
124, TimePoint, 2193, 2199, "day 60", "", 
182, IOP, 2202, 2205, "IOP", "", 
183, RelativeTime, 2219, 2257, "just before instillation of medication", "", 
184, TimePoint, 2260, 2264, "9 AM", "", 
179, RelativeTime, 2271, 2284, "2 hours after", "", 
185, TimePoint, 2287, 2292, "11 AM", "", 
55, HeartRate, 2398, 2408, "heart rate", "", 
56, BloodPressure, 2413, 2427, "blood pressure", "", 
193, TimePoint, 2430, 2435, "10 AM", "", 
60624, EndPointDescription, 2442, 2458, "ocular tolerance", "", 
195, RelativeTime, 2459, 2475, "after medication", "", 
194, TimePoint, 2478, 2483, "11 AM", "", 
34, IOP, 2539, 2542, "IOP", "", 
60628, TimePoint, 2548, 2556, "baseline", "", 
197, TimePoint, 2560, 2566, "day 60", "", 
198, TimePoint, 2591, 2595, "9 AM", "", 
199, TimePoint, 2600, 2605, "11 AM", "", 
117, IOP, 2650, 2653, "IOP", "", 
125, TimePoint, 2657, 2662, "day 0", "", 
22, NumberPatientsCT, 2723, 2726, "151", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasNumberPatientsCT> \"151\"."
82, FinalNumPatientsCT, 2760, 2763, "149", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasFinalNumberPatientsCT> \"149\"."
83, NumPatientsLeftCT, 2781, 2784, "two", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasNumPatientsLeftCT> \"two\"."
204, FinalNumPatientsArm, 2835, 2837, "74", "", "<http://ctro/data#Arm_38956> <http://ctro/data#hasFinalNumPatientsArm> \"74\"."
205, FinalNumPatientsArm, 2864, 2866, "75", "", "<http://ctro/data#Arm_38965> <http://ctro/data#hasFinalNumPatientsArm> \"75\"."
84, BloodPressure, 2965, 2979, "blood pressure", "", 
46, IOP, 2986, 2989, "IOP", "", 
212, TimePoint, 3013, 3020, "09 . 00", "", 
52, Trough_IOP, 3038, 3044, "trough", "", "<http://ctro/data#Endpoint_38951> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Trough_IOP>."
37, TimePoint, 3050, 3056, "day 60", "", "<http://ctro/data#Outcome_39000> <http://ctro/data#hasTimePoint> \"day 60\". <http://ctro/data#Outcome_39027> <http://ctro/data#hasTimePoint> \"day 60\"."
38, Mean, 3059, 3063, "mean", "", "<http://ctro/data#Mean_38953> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_38951> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_38953>."
60645, TimePoint, 3080, 3088, "baseline", "", 
45, Trough_IOP, 3092, 3112, "intraocular pressure", "", 
39, Reduction, 3118, 3124, "6 . 32", "", "<http://ctro/data#Outcome_39027> <http://ctro/data#hasChangeValue> \"6 . 32\"."
60658, SdDevChangeValue, 3131, 3137, "2 . 87", "", "<http://ctro/data#Outcome_39027> <http://ctro/data#hasSdDevChangeValue> \"2 . 87\"."
41, Reduction, 3142, 3148, "5 . 67", "", "<http://ctro/data#Outcome_39000> <http://ctro/data#hasChangeValue> \"5 . 67\"."
60660, SdDevChangeValue, 3155, 3161, "3 . 30", "", "<http://ctro/data#Outcome_39000> <http://ctro/data#hasSdDevChangeValue> \"3 . 30\"."
43, mmHg, 3162, 3166, "mmHg", "", "<http://ctro/data#Endpoint_38951> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
96, Drug, 3175, 3193, "alginate carteolol", "", 
213, TimePoint, 3234, 3241, "11 . 00", "", "<http://ctro/data#Outcome_52125> <http://ctro/data#hasTimePoint> \"11 . 00\". <http://ctro/data#Outcome_52152> <http://ctro/data#hasTimePoint> \"11 . 00\"."
53, Peak_IOP, 3259, 3263, "peak", "", "<http://ctro/data#Endpoint_38951> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Trough_IOP>."
44, Mean, 3268, 3272, "mean", "", "<http://ctro/data#Mean_38948> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_38946> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_38948>."
47, Reduction, 3289, 3295, "6 . 70", "", "<http://ctro/data#Outcome_52125> <http://ctro/data#hasChangeValue> \"6 . 70\"."
260, SdDevChangeValue, 3302, 3308, "2 . 81", "", "<http://ctro/data#Outcome_52125> <http://ctro/data#hasSdDevChangeValue> \"2 . 81\"."
48, Reduction, 3313, 3319, "6 . 55", "", "<http://ctro/data#Outcome_52152> <http://ctro/data#hasChangeValue> \"6 . 55\"."
261, SdDevChangeValue, 3326, 3332, "3 . 35", "", "<http://ctro/data#Outcome_52152> <http://ctro/data#hasSdDevChangeValue> \"3 . 35\"."
51, mmHg, 3333, 3337, "mmHg", "", "<http://ctro/data#Endpoint_38946> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
54, PValueChangeValue, 3434, 3445, "p < 0 . 005", "", "<http://ctro/data#Outcome_39000> <http://ctro/data#hasPValueChangeValue> \"p < 0 . 005\". <http://ctro/data#Outcome_39027> <http://ctro/data#hasPValueChangeValue> \"p < 0 . 005\". <http://ctro/data#Outcome_52125> <http://ctro/data#hasPValueChangeValue> \"p < 0 . 005\". <http://ctro/data#Outcome_52152> <http://ctro/data#hasPValueChangeValue> \"p < 0 . 005\"."
57, BloodPressure, 3566, 3580, "blood pressure", "", 
60, ObservedResult, 3592, 3746, "Slight decreases in heart rate and blood pressure means were observed in both groups at follow - up visits with no significant difference between groups .", "", 
59, HeartRate, 3612, 3622, "heart rate", "", 
58, BloodPressure, 3627, 3641, "blood pressure", "", 
222, Mean, 3642, 3647, "means", "", 
223, TimePoint, 3818, 3824, "day 60", "", 
224, PercentageAffected, 3828, 3831, "100", "", 
225, PercentageAffected, 3862, 3868, "98 . 7", "", 
60676, EndPointDescription, 3894, 3914, "Transient discomfort", "", "<http://ctro/data#EndPointDescription_52182> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_52181> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_52182>."
226, Stinging, 3924, 3932, "stinging", "", 
60679, EndPointDescription, 3936, 3953, "burning sensation", "", 
60682, PercentageAffected, 3986, 3995, "4 % - 6 %", "", 
92864, BlurredVison, 4050, 4064, "blurred vision", "", 
61, NumberAffected, 4091, 4092, "2", "", 
118, NumberPatientsArm, 4100, 4102, "74", "", 
233, NumberAffected, 4146, 4148, "17", "", 
60687, EndPointDescription, 4158, 4172, "adverse events", "", 
63, NumberAffected, 4215, 4218, "one", "", "<http://ctro/data#Outcome_52201> <http://ctro/data#hasNumberAffected> \"one\"."
60688, EndPointDescription, 4219, 4226, "vertigo", "", "<http://ctro/data#EndPointDescription_52187> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_52186> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_52187>."
65, NumberAffected, 4229, 4232, "one", "", "<http://ctro/data#Outcome_52228> <http://ctro/data#hasNumberAffected> \"one\"."
60689, EndPointDescription, 4233, 4263, "superficial punctate keratitis", "", "<http://ctro/data#EndPointDescription_52192> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_52191> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_52192>."
66, NumberAffected, 4290, 4293, "one", "", "<http://ctro/data#Outcome_52255> <http://ctro/data#hasNumberAffected> \"one\"."
60691, EndPointDescription, 4294, 4320, "decrease in blood pressure", "", "<http://ctro/data#EndPointDescription_52197> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_52196> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_52197>."
236, ObservedResult, 4345, 4384, "No serious adverse events were reported", "", 
68, ConclusionComment, 4401, 4589, "The new alginate formulation of long - acting carteolol 1 % given once daily is as effective as standard 1 % carteolol given twice daily , with no meaningful differences regarding safety .", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasConclusionComment> \"The new alginate formulation of long - acting carteolol 1 % given once daily is as effective as standard 1 % carteolol given twice daily , with no meaningful differences regarding safety .\"."
60701, Drug, 4409, 4456, "alginate formulation of long - acting carteolol", "", 
72, DoseValue, 4457, 4458, "1", "", 
74, Percentage, 4459, 4460, "%", "", 
76, Frequency, 4467, 4477, "once daily", "", 
73, DoseValue, 4506, 4507, "1", "", 
75, Percentage, 4508, 4509, "%", "", 
91, Carteolol, 4510, 4519, "carteolol", "", 
77, Frequency, 4526, 4537, "twice daily", "", 
69, ConclusionComment, 4590, 4784, "This efficacy wasy was verified at 9 AM ( 24 hours after the last drop of long - acting carteolol or 12 hours after that of standard carteolol ) and at 11 AM ( 2 hours after the morning drop ) .", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasConclusionComment> \"This efficacy wasy was verified at 9 AM ( 24 hours after the last drop of long - acting carteolol or 12 hours after that of standard carteolol ) and at 11 AM ( 2 hours after the morning drop ) .\"."
60760, Drug, 4664, 4687, "long - acting carteolol", "", 
92, Carteolol, 4723, 4732, "carteolol", "", 
70, ConclusionComment, 4785, 4946, "The new alginate formulation of long - acting carteolol 1 % given once a day is effective and well tolerated by glaucoma patients who require chronic treatment .", "", "<http://ctro/data#ClinicalTrial_38914> <http://ctro/data#hasConclusionComment> \"The new alginate formulation of long - acting carteolol 1 % given once a day is effective and well tolerated by glaucoma patients who require chronic treatment .\"."
98, Drug, 4793, 4840, "alginate formulation of long - acting carteolol", "", 
78, DoseValue, 4841, 4842, "1", "", 
79, Percentage, 4843, 4844, "%", "", 
80, Frequency, 4851, 4861, "once a day", "", 
81, Glaucoma, 4897, 4905, "glaucoma", "", 
71, PMID, 4954, 4962, "12660585", "", "<http://ctro/data#Publication_19083> <http://ctro/data#hasPMID> \"12660585\"."
